AVDL - Avadel Pharmaceuticals PLC
Avadel Pharmaceuticals PLC Logo

AVDL - Avadel Pharmaceuticals PLC

https://www.avadel.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bullish
This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Archrock ( NYSE:AROC ) , Alkermes ( NASDAQ:ALKS )
Benzinga • 1 week, 5 days ago • score: 0.17
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Compass Point analyst Ed Engel initiated coverage on Bullish BLSH with a Neutral rating and ...
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Avadel Pharmaceuticals plc is a biopharmaceutical company in the United States. The company is headquartered in Dublin, Ireland.

52W High
$16.66
52W Low
$6.38
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.63
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
12.82
EV/EBITDA (<8 favorable)
184.54
EV/Revenue (<3 favorable)
6.57
P/S (TTM) (<3 favorable)
6.92
P/B (<3 favorable)
16.87
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
4.89%
Institutions (25–75% balanced)
86.38%
Shares Outstanding
97,098,000
Float
80,643,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
221,075,000
Gross Profit (TTM)
198,165,000
EPS (TTM)
-0.02
Profit Margin (>10% good)
-0.01%
Operating Margin (TTM) (higher better)
0.13%
ROE (TTM) (>15% strong)
-0.04%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.64
Momentum
Bearish momentum
Value
1.0577
Previous
1.0648
Trend
Falling
Signal Cross
No cross
As of
Sep. 11, 2025